Reference data : LOINC code

Filter


Clear filter

Results
104,672 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType DefinitionDescription dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
59671-8 Estazolam MCnt Tiss Pt Qn Confirm   ACTIVE Estazolam [Mass/mass] in Tissue by Confirmatory method   MIN DefinitionDescription     ng/g 5 ng/g           DRUG/TOX   59671-8   Confirm     Both       0 Estazolam Tiss Cfm-mCnt       N   Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Esilgan; Eurodin; GCMS; LC/MS/MS; Mass content; Nuctalon; Point in time; Prosom; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified 2.7 2.32               ng/g       0
59672-6 Estazolam MCnc Urine Pt Qn Confirm   ACTIVE Estazolam [Mass/volume] in Urine by Confirmatory method   MIN DefinitionDescription     ng/mL 5 ng/mL           DRUG/TOX   59672-6   Confirm     Both       0 Estazolam Ur Cfm-mCnc       N   Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Esilgan; Eurodin; GCMS; LC/MS/MS; Level; Mass concentration; Nuctalon; Point in time; Prosom; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn 2.73 2.32               ng/mL       0
59673-4 fentaNYL PrThr Urine Pt Ord Screen   ACTIVE fentaNYL [Presence] in Urine by Screen method   MIN DefinitionDescription       1 ng/mL           DRUG/TOX   59673-4   Screen     Both       0 fentaNYL Ur Ql Scn       N   Actiq; Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Duragesic; Durogesic; Fenpat; fentanil; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Sublimaze; UA; UR; Urn 2.73 2.32                     The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
59674-2 Flurazepam MCnc Bld Pt Qn     ACTIVE Flurazepam [Mass/volume] in Blood   MIN DefinitionDescription     ng/mL 2 ng/mL           DRUG/TOX   59674-2         Both       0 Flurazepam Bld-mCnc       N   Blood; Dalmane; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood 2.73 2.32               ng/mL       0
59675-9 Flurazepam MCnc Bld Pt Qn Confirm   ACTIVE Flurazepam [Mass/volume] in Blood by Confirmatory method   MIN DefinitionDescription     ng/mL 2 ng/mL           DRUG/TOX   59675-9   Confirm     Both       0 Flurazepam Bld Cfm-mCnc       N   Blood; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Dalmane; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood 2.73 2.32               ng/mL       0
59676-7 Flurazepam MCnc Body fld Pt Qn     ACTIVE Flurazepam [Mass/volume] in Body fluid   MIN DefinitionDescription     ng/mL 2 ng/mL           DRUG/TOX   59676-7         Both       0 Flurazepam Fld-mCnc       N   B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Dalmane; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random 2.7 2.32               ng/mL       0
59677-5 Flurazepam MCnc Body fld Pt Qn Confirm   ACTIVE Flurazepam [Mass/volume] in Body fluid by Confirmatory method   MIN DefinitionDescription     ng/mL 2 ng/mL           DRUG/TOX   59677-5   Confirm     Both       0 Flurazepam Fld Cfm-mCnc       N   B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Dalmane; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; GCMS; LC/MS/MS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random 2.73 2.32               ng/mL       0
59678-3 Flurazepam MCnt Tiss Pt Qn     ACTIVE Flurazepam [Mass/mass] in Tissue   MIN DefinitionDescription     ng/g 2 ng/g           DRUG/TOX   59678-3         Both       0 Flurazepam Tiss-mCnt       N   Dalmane; DRUG/TOXICOLOGY; Drugs; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified 2.7 2.32               ng/g       0
59679-1 Flurazepam MCnt Tiss Pt Qn Confirm   ACTIVE Flurazepam [Mass/mass] in Tissue by Confirmatory method   MIN DefinitionDescription     ng/g 2 ng/g           DRUG/TOX   59679-1   Confirm     Both       0 Flurazepam Tiss Cfm-mCnt       N   Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Dalmane; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified 2.7 2.32               ng/g       0
5968-3 Plasminogen activator tissue type^20M post venistasis MCnc PPP Pt Qn Enzy   DEPRECATED Deprecated Plasminogen activator tissue type [Units/volume] in Platelet poor plasma by Chromogenic method --20 minutes post venistasis   DEL DefinitionDescription                   COAG   5968-3   Enzy             0 Deprecated tPA 20M PPP-mCnc           After; Blood plasminogen activator; COAGULATION; Hematology; Heme; Level; Mass concentration; Plas; Platelet poor plasma; PLG; PLGN; Point in time; Profibrinolysin; PST; QNT; Quan; Quant; Quantitative; Random; Tissue plasminogen activator; TPA; t-PA; Vascular plasminogen activator 2.36 1.0d       AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
59680-9 Gabapentin MCnc Urine Pt Qn     ACTIVE Gabapentin [Mass/volume] in Urine   MIN DefinitionDescription     ug/mL 0.1 mcg/mL           DRUG/TOX   59680-9         Both       0 Gabapentin Ur-mCnc       N   DRUG/TOXICOLOGY; Drugs; Horizant; Level; Mass concentration; Neurontin; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn 2.73 2.32               ug/mL       0
59681-7 Gamma hydroxybutyrate PrThr Ser/Plas Pt Ord Screen   ACTIVE Gamma hydroxybutyrate [Presence] in Serum or Plasma by Screen method   MIN DefinitionDescription       2 mcg/mL           DRUG/TOX   59681-7   Screen     Both       0 G-OH-Butyr SerPl Ql Scn       N   4-hydroxybutyrate; 4-hydroxybutyric acid; DRUG/TOXICOLOGY; Drugs; Gamma hydroxy butyrate; Gamma-hydroxybutyrate; Gamma-OH; GBH; Georgia home boy; GHb; G-OH-Butyr; Goop; Hydroxybutyric acid; Liquidx; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.73 2.32                     The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
59682-5 Hydroxyethylflurazepam MCnc Bld Pt Qn     ACTIVE Hydroxyethylflurazepam [Mass/volume] in Blood   MIN DefinitionDescription     ng/mL 5 ng/mL           DRUG/TOX   59682-5         Both       0 OH-Ethylfluraz Bld-mCnc       N   Blood; DRUG/TOXICOLOGY; Drugs; Flurazepam metabolite; Hydroxy ethylflurazepam; Level; Mass concentration; OH-Ethylfluraz; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood 2.7 2.32               ng/mL       0
59683-3 Hydroxyethylflurazepam MCnc Bld Pt Qn Confirm   ACTIVE Hydroxyethylflurazepam [Mass/volume] in Blood by Confirmatory method   MIN DefinitionDescription     ng/mL 5 ng/mL           DRUG/TOX   59683-3   Confirm     Both       0 OH-Ethylfluraz Bld Cfm-mCnc       N   Blood; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Flurazepam metabolite; GCMS; Hydroxy ethylflurazepam; LC/MS/MS; Level; Mass concentration; OH-Ethylfluraz; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood 2.7 2.32               ng/mL       0
59684-1 Hydroxyethylflurazepam MCnc Body fld Pt Qn     ACTIVE Hydroxyethylflurazepam [Mass/volume] in Body fluid   MIN DefinitionDescription     ng/mL 5 ng/mL           DRUG/TOX   59684-1         Both       0 OH-Ethylfluraz Fld-mCnc       N   B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; Flurazepam metabolite; Hydroxy ethylflurazepam; Level; Mass concentration; OH-Ethylfluraz; Point in time; QNT; Quan; Quant; Quantitative; Random 2.7 2.32               ng/mL       0
59685-8 Hydroxyethylflurazepam MCnc Body fld Pt Qn Confirm   ACTIVE Hydroxyethylflurazepam [Mass/volume] in Body fluid by Confirmatory method   MIN DefinitionDescription     ng/mL 5 ng/mL           DRUG/TOX   59685-8   Confirm     Both       0 OH-Ethylfluraz Fld Cfm-mCnc       N   B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; Flurazepam metabolite; GCMS; Hydroxy ethylflurazepam; LC/MS/MS; Level; Mass concentration; OH-Ethylfluraz; Point in time; QNT; Quan; Quant; Quantitative; Random 2.7 2.32               ng/mL       0
59686-6 Hydroxyethylflurazepam MCnt Meconium Pt Qn Confirm   ACTIVE Hydroxyethylflurazepam [Mass/mass] in Meconium by Confirmatory method   MIN DefinitionDescription     ng/g 5 ng/g           DRUG/TOX   59686-6   Confirm     Both       0 OH-Ethylfluraz Mec Cfm-mCnt       N   Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Flurazepam metabolite; GCMS; Hydroxy ethylflurazepam; LC/MS/MS; Mass content; Mec; OH-Ethylfluraz; Point in time; QNT; Quan; Quant; Quantitative; Random 2.7 2.32               ng/g       0
59687-4 Hydroxyethylflurazepam MCnt Stool Pt Qn Confirm   ACTIVE Hydroxyethylflurazepam [Mass/mass] in Stool by Confirmatory method   MIN DefinitionDescription     ng/g 5 ng/g           DRUG/TOX   59687-4   Confirm     Both       0 OH-Ethylfluraz Stl Cfm-mCnt       N   Bowel movement; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Faecal; Faeces; Fecal; Feces; Flurazepam metabolite; GCMS; Hydroxy ethylflurazepam; LC/MS/MS; Mass content; OH-Ethylfluraz; Point in time; QNT; Quan; Quant; Quantitative; Random; Stl; Stool = Fecal 2.7 2.32               ng/g       0
59688-2 Hydroxyethylflurazepam MCnt Tiss Pt Qn     ACTIVE Hydroxyethylflurazepam [Mass/mass] in Tissue   MIN DefinitionDescription     ng/g 5 ng/g           DRUG/TOX   59688-2         Both       0 OH-Ethylfluraz Tiss-mCnt       N   DRUG/TOXICOLOGY; Drugs; Flurazepam metabolite; Hydroxy ethylflurazepam; Mass content; OH-Ethylfluraz; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified 2.7 2.32               ng/g       0
59689-0 Hydroxyethylflurazepam MCnt Tiss Pt Qn Confirm   ACTIVE Hydroxyethylflurazepam [Mass/mass] in Tissue by Confirmatory method   MIN DefinitionDescription     ng/g 5 ng/g           DRUG/TOX   59689-0   Confirm     Both       0 OH-Ethylfluraz Tiss Cfm-mCnt       N   Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Flurazepam metabolite; GCMS; Hydroxy ethylflurazepam; LC/MS/MS; Mass content; OH-Ethylfluraz; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified 2.7 2.32               ng/g       0
5969-1 Plasmin-plasmin inhibitor complex MCnc PPP Pt Qn IA   ACTIVE Plasmin-plasmin inhibitor complex [Mass/volume] in Platelet poor plasma by Immunoassay   MAJ DefinitionDescription                   COAG   5969-1   IA     Both       0 PAP PPP IA-mCnc       Y   Alpha-2-anti plasmin; Alpha-2-antiplasmin; Alpha-2-AP; Antiplasmin; COAGULATION; Compx; EIA; ELFA; ELISA; Enzyme immunoassay; Hematology; Heme; IAA; Inhib; Inhibit; Level; Mass concentration; MEIA; PAP; Plas; Plasm Inhib; Plasmin-alpha-2-antiplasmin complex; Platelet poor plasma; Point in time; Primary fibrinolysis inhibitor; Primary plasmin inhibitor; QNT; Quan; Quant; Quantitative; Random; SUDS 2.58 1.0d                     Renamed Method from "Imm" to "IA" for consistency across classes (approved by Laboratory LOINC Committee 2016 12). 0
59690-8 Hydroxytriazolam MCnc Bld Pt Qn     ACTIVE Hydroxytriazolam [Mass/volume] in Blood   MIN DefinitionDescription     ng/mL 5 ng/mL           DRUG/TOX   59690-8         Both       0 OH-Triazolam Bld-mCnc       N   Addiction; Blood; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Hydroxy triazolam; Illicit; Level; Mass concentration; OH-Triazolam; OHTRZ; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Triazolam metabolite; WB; Whole blood 2.73 2.32               ng/mL       0
59691-6 Hydroxytriazolam MCnc Bld Pt Qn Confirm   ACTIVE Hydroxytriazolam [Mass/volume] in Blood by Confirmatory method   MIN DefinitionDescription     ng/mL 5 ng/mL           DRUG/TOX   59691-6   Confirm     Both       0 OH-Triazolam Bld Cfm-mCnc       N   Addiction; Blood; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Hydroxy triazolam; Illicit; LC/MS/MS; Level; Mass concentration; OH-Triazolam; OHTRZ; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Triazolam metabolite; WB; Whole blood 2.7 2.32               ng/mL       0
59692-4 Hydroxytriazolam MCnc Body fld Pt Qn     ACTIVE Hydroxytriazolam [Mass/volume] in Body fluid   MIN DefinitionDescription     ng/mL 5 ng/mL           DRUG/TOX   59692-4         Both       0 OH-Triazolam Fld-mCnc       N   Addiction; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Fl; Fld; FLU; Fluid; Hydroxy triazolam; Illicit; Level; Mass concentration; OH-Triazolam; OHTRZ; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Triazolam metabolite 2.7 2.32               ng/mL       0
59693-2 Hydroxytriazolam MCnc Body fld Pt Qn Confirm   ACTIVE Hydroxytriazolam [Mass/volume] in Body fluid by Confirmatory method   MIN DefinitionDescription     ng/mL 5 ng/mL           DRUG/TOX   59693-2   Confirm     Both       0 OH-Triazolam Fld Cfm-mCnc       N   Addiction; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Fl; Fld; FLU; Fluid; GCMS; Hydroxy triazolam; Illicit; LC/MS/MS; Level; Mass concentration; OH-Triazolam; OHTRZ; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Triazolam metabolite 2.7 2.32               ng/mL       0
104,672 results found